Pricing

Log inSign up

Michael Artinger

CEO at i-Seq Biotechnology

No bio yet

Location

Minneapolis, United States

Links

Org chart

No direct reports

Teams

This person is not in any teams

Offices

i-Seq Biotechnology

i-Seq Biotechnology, Inc. was formed in 2024 to advance novel, broad-spectrum, vaccines and therapeutics against infectious disease pathogens impacting human health globally.

Industries

Biotechnology, Life Sciences

Headquarters

Mobile , United States

Employees

1-10

Links

Related people